Dr. Jason Lamar Aldred, MD

Dr. Aldred practices at Selkirk Neurology in Spokane, Washington.

Dr. Aldred's NPI, 1003969684, was assigned on January 19, 2007. Dr. Aldred graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 2003. Dr. Aldred holds Washington license MD60441119.

Dr. Aldred's primary practice is Selkirk Neurology, at 610 S Sherman St, Spokane, WA 99202 in Spokane County. The practice phone is (509) 473-0885.

Dr. Aldred's primary practice is Selkirk Neurology in Spokane, Washington. Dr. Aldred is also affiliated with Providence St. Luke's Rehabilitation Medical Center. The medical group on file is Selkirk Neurology. Dmand AI also links Dr. Aldred to 3 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aldred practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Aldred's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Aldred is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Aldred's licenses on file in 8 states: Washington, Oregon, Arizona, Idaho, Montana, Wisconsin, Iowa and Minnesota.

Dmand AI lists alzheimer's disease, cerebrovascular disease, essential tremor, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, migraine and chronic headache and mobility impairment among the conditions Dr. Aldred treats.

CMS data shows 62,959 Medicare services from Dr. Aldred across 32 procedure codes in 2024, for 821 Medicare patients. Medicare paid $671,181 for them. Every service was in an office.

CMS counts 821 Medicare patients who saw Dr. Aldred in 2024. The largest group is 75 to 84, with 354 patients. 62% of them have high cholesterol, and 59% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Aldred's median patient age at 70, with 52% women.

In 2024, Dr. Aldred wrote 5,006 Medicare Part D claims for 544 patients. 84% of them were for generic drugs. CMS names the drug for 4,728 of them, across 55 drugs with 11 or more claims each, at $2,794,030 in total drug cost. In 2023, CMS named 3,490 claims across 51 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Aldred for performance year 2024, reported individually. Dr. Aldred accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aldred as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 26 papers to Dr. Aldred, published from 2012 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Parkinson Disease, Antiparkinson Agents and Carbidopa. Dr. Aldred has published most often in J Parkinsons Dis. Dr. Aldred's most frequent co-authors are David G. Standaert, Rajesh Pahwa, MD and Thomas L. Davis, MD.

Dmand AI links Dr. Aldred to 20 clinical trials, 6 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Parkinson Disease, Parkinsonian Disorders and Parkinson Disease 4, Autosomal Dominant Lewy Body. ACADIA Pharmaceuticals Inc. sponsors the most, 3. Open Payments lists research payments to Dr. Aldred that name 3 trials.

CMS Open Payments shows 1,889 general payments to Dr. Aldred from 48 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 74% of the total. Abbvie Inc. paid the most, $510,767. It also lists 25 research payments totaling $91,133 from 2018 to 2022, naming 3 clinical trials.

Dmand AI lists 8 awards for Dr. Aldred, most recently CMS Stage 1 EHR in 2012. Dr. Aldred serves on MDS Telemedicine Committee and Parkinson's Disease Practice Guidelines Committee.

Dr. Aldred graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 2003. Dr. Aldred is a member of AAN, Dystonia Study Group, MDS, Movement Disorders Society and Parkinson Study Group.

Dr. Aldred is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.